Topic: Biology
Researchers at Texas A&M University have developed a nasal spray that can reverse brain aging. The treatment reduced chronic inflammation and improved memory after just two doses.
Imagine being able to undo some of the mental decline that comes with age. That's exactly what scientists at Texas A&M University have achieved using a simple nasal spray.
The team, led by Dr. Ashok Shetty, has been studying how aging brains experience persistent low-level inflammation, known as neuroinflammaging. This chronic inflammation can interfere with memory, thinking, and the brain's ability to adapt to new situations. It is also considered a major contributor to neurodegenerative diseases like dementia and Alzheimer's disease.
The researchers used microscopic biological particles called extracellular vesicles (EVs) to deliver microRNAs, molecules that help regulate important biological processes in the brain. The treatment targeted immune cells involved in chronic inflammation and restored activity in mitochondria, the tiny structures inside cells responsible for producing energy.
The improvements were not limited to biological measurements. Behavioral testing showed that treated models performed significantly better on memory and recognition tasks.
The team believes their approach could eventually lead to new therapies for conditions tied to aging and cognitive decline. The findings have been published in the Journal of Extracellular Vesicles.
This breakthrough has significant implications for brain health and dementia research. With further development, a simple nasal spray could one day replace invasive procedures and help people stay mentally sharp as they age.
Why It Matters
As India's population ages, understanding how to reverse or slow down cognitive decline is crucial. This breakthrough could lead to new treatments that help older adults maintain their mental health and independence.
Key Facts
- The nasal spray treatment reduced chronic inflammation in the brain after just two doses.
- The treatment restored activity in mitochondria, which can improve energy production in brain cells.
- Behavioral testing showed improved memory and recognition tasks in treated models.
- The team believes their approach could lead to new therapies for dementia and Alzheimer's disease.
- The findings were published in the Journal of Extracellular Vesicles.
Key Terms
- Neuroinflammaging
- A process where chronic inflammation occurs in the brain, leading to age-related cognitive decline.
Implications
As India's population ages, understanding how to reverse or slow down cognitive decline is crucial. This breakthrough could lead to new treatments that help older adults maintain their mental health and independence.
Source: https://www.sciencedaily.com/releases/2026/05/260526022018.htm
Journal Reference:
- Leelavathi N. Madhu, Maheedhar Kodali, Shama Rao, Sahithi Attaluri, Raghavendra Upadhya, Goutham Shankar, Bing Shuai, Yogish Somayaji, Shruthi V. Ganesh, Vignesh S. Kumar, Jeswin E. James, Padmashri A. Shetty, Avery LeMaire, Xiaolan Rao, James J Cai, Ashok K. Shetty. Intranasal Human NSC‐Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS‐STING Signalling, in Aged Hippocampus. Journal of Extracellular Vesicles, 2026; 15 (2) DOI: 10.1002/jev2.70232
Leave a Comment